Overview
David Fogelman is a Hematologist Oncology provider in Houston, Texas. Dr. Fogelman is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatoblastoma, Ampullary Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
His clinical research consists of co-authoring 88 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
MD Anderson
Arvind Dasari is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Dasari is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Neuroendocrine Tumor, Colorectal Cancer, Familial Colorectal Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Baylor College Of Medicine
Tannaz Armaghany is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Armaghany is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Neuroendocrine Tumor, Fibrolamellar Carcinoma, Gallbladder Adenocarcinoma, and Gallbladder Cancer. Dr. Armaghany is currently accepting new patients.
MD Anderson
Robert Wolff is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Wolff is rated as an Elite provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- PancreaticoduodenectomyDr. Fogelman isDistinguished. Learn about Pancreaticoduodenectomy.
- Advanced
- Ampullary CancerDr. Fogelman isAdvanced. Learn about Ampullary Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Gastroesophageal Junction CancerDr. Fogelman isAdvanced. Learn about Gastroesophageal Junction Cancer.
- GlucagonomaDr. Fogelman isAdvanced. Learn about Glucagonoma.
- Lynch SyndromeDr. Fogelman isAdvanced. Learn about Lynch Syndrome.
- PancreatectomyDr. Fogelman isAdvanced. Learn about Pancreatectomy.
- Experienced
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Fogelman isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- HypersplenismDr. Fogelman isExperienced. Learn about Hypersplenism.
- Liver CancerDr. Fogelman isExperienced. Learn about Liver Cancer.
- Metastatic InsulinomaDr. Fogelman isExperienced. Learn about Metastatic Insulinoma.
- Multiple Endocrine NeoplasiaDr. Fogelman isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 1Dr. Fogelman isExperienced. Learn about Multiple Endocrine Neoplasia Type 1.